Alex Therapeutics is a brand that is dedicated to democratizing healthcare through the integration of Psychology, Design, and Technology. They aim to make cognitive behavioral therapy (CBT) more accessible and effective for treating a wide range of mental health disorders. CBT has been proven to be immensely powerful, but it remains under-utilized.

By leveraging technology and design, Alex Therapeutics lowers the threshold for accessing high-quality psychological treatment, breaks the stigma surrounding receiving help, and addresses various medical indications that are currently left untreated. The company was founded by John Drakenberg Renander, an entrepreneur with a background in Psychology and Business, and Oliver Fleetwood, who holds a PhD in Theoretical Computational Molecular Biophysics. Alex Therapeutics is supported by the King founders (Candy Crush) through the VC firm Sweet Studio.

Through their DTx platform, Alex Therapeutics offers a range of digital therapeutics products aimed at addressing different healthcare needs. One of their products, Alex - Quit Smoking Almee™, is designed to help individuals overcome smoking addiction. Alex Therapeutics is committed to improving healthcare outcomes and making a positive impact on people's lives